TAPIMMUNE INC Chart calendar TapImmune Inc
090da18ee0a4.qxhpngUSpUYwBPeEHDcc5MF6-M3_I337rMqt_m2u6OA.8kAExFp5xhBmN5K9TwUr05k-i4CdaCrW3Kb7nSrA36fRKwXJXSPjFwcxog~2cf776695ef575c23732cdcfaff4462b
Upcoming events on TapImmune Inc
Past events on TapImmune Inc
| 02/04/2024 | Hematologic Malignancies Global Summit |
| 26/03/2024 07:30 pm | H.C. Wainwright Cell Therapy Virtual Conference |
| 26/03/2024 03:15 am | Q4 2023 Earnings Release |
| 10/01/2024 | Non Dilutive Funding Summit |
| 08/01/2024 | Biotech Showcase |
| 10/11/2023 03:30 am | Q3 2023 Earnings Release |
| 13/09/2023 06:00 pm | H.C. Wainwright Global Investment Conference |
| 15/08/2023 02:00 am | Q2 2023 Earnings Release |
| 06/06/2023 06:30 pm | Annual General Meeting |
| 22/03/2023 05:40 pm | Q4 2022 Earnings Release |
| 11/11/2022 02:35 am | Q3 2022 Earnings Release |
| 15/09/2022 06:50 pm | Cantor Fitzgerald Cell & Gene Therapy Conference |
| 12/08/2022 01:52 am | Interim 2022 Earnings Release |
| 24/05/2022 06:30 pm | Annual General Meeting |
| 13/05/2022 04:30 pm | Q1 2022 Earnings Release |
| 06/05/2022 06:15 am | International Society for Cell & Gene Therapy Meeting - Abstract Number : 506 |
| 06/05/2022 06:15 am | International Society for Cell & Gene Therapy Meeting - Abstract Number : 936 |
| 06/05/2022 06:15 am | International Society for Cell & Gene Therapy Meeting - Abstract Number : 515 |
| 06/05/2022 06:15 am | International Society for Cell & Gene Therapy Meeting - Abstract Number : 937 |
| 18/03/2022 03:15 am | FY 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,21 0,00 - | 0,47 0,48 -3.46% | 1,24 0,00 - | 9,01 9,00 0.15% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -22,5 -23,2 2.92% | -28,9 -27,8 -3.86% | -39,5 -40,5 2.49% | 0,00 0,00 - | -18,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,4 -22,2 3.26% | -28,7 -27,7 -3.56% | -41,9 -42,3 0.95% | 0,00 0,00 - | -17,4 |
|
Net income Million USD | Released Forecast Spread | -21,4 -22,2 3.26% | -28,7 -27,7 -3.56% | -41,9 -42,3 0.95% | 0,00 0,00 - | -17,4 |
|
EPS USD | Released Forecast Spread | -4,70 -4,86 3.29% | -6,10 -5,90 -3.39% | -5,50 -5,73 3.93% | -3,58 -3,60 0.56% | -1,28 |
| Announcement Date | 12/03/20 | 09/03/21 | 17/03/22 | 22/03/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,24 0,00 - | 0,96 0,00 - | 0,79 2,50 -68.38% | 3,95 0,27 1381.07% | 3,31 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,76 -10,8 9.21% | -9,79 -11,2 12.55% | -9,28 -8,72 -6.46% | -7,02 -11,3 37.7% | -2,45 | -2,57 | -5,29 | -7,93 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,76 -10,8 9.38% | -9,91 -11,2 11.25% | -9,24 -8,74 -5.81% | -6,92 -10,9 36.23% | -2,26 | -2,42 | -5,17 | -7,53 | |
|
Net income Million USD | Released Forecast Spread | -9,76 -10,8 9.38% | -9,91 -11,2 11.25% | -9,24 -8,74 -5.81% | -6,92 -10,9 36.23% | -2,26 | -2,42 | -5,17 | -7,53 | |
|
EPS USD | Released Forecast Spread | -1,10 -1,28 13.73% | -1,20 -1,33 10% | -1,10 -1,05 -4.76% | -0,80 -1,30 38.46% | -3,27 -1,00 -227% | -0,25 | -0,27 | -0,37 | -0,39 |
| Announcement Date | 17/03/22 | 13/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | - | - | - | - |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 10:30 am | VALNEVA: Q1 2024 Earnings Release |
| 07/05/2024 04:30 pm | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for TapImmune Inc
| 03/05/2024 01:40 am | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:35 pm | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
